| Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping (NCT06048458) | University College, London | 2022-05-18 |
| Does Genetic Susceptibility for Bleeding Affect Quantitative Faecal Immunochemical Test (qFIT) Results? (NCT05329870) | University of Edinburgh | 2022-05-18 |
| Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers (NCT05114798) | University of Illinois at Chicago | 2022-05-17 |
| Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life (NCT05242562) | Radboud University Medical Center | 2022-05-16 |
| Supervised Exercise for Post-surgery Colorectal Cancer Patients (NCT05090215) | University of Nottingham | 2022-05-13 |
| Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention (NCT05338307) | Abramson Cancer Center at Penn Medicine | 2022-05-13 |
| Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages (NCT05445570) | Venn Biosciences Corporation | 2022-05-13 |
| It is Possible to Maintain the Performance of Screening Colonoscopies Under MEOPA During the Covid 19 Epidemic Period When Access to the Operating Room is Limited (NCT05336617) | Centre Hospitalier Sud Francilien | 2022-05-13 |
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors (NCT05311618) | NGM Biopharmaceuticals, Inc | 2022-05-11 |
| Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer (NCT05371197) | Third Affiliated Hospital, Sun Yat-Sen University | 2022-05-05 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Interventions to Improve Bowel Cancer Screening Uptake in Ireland: a 2x2 Factorial Trial (NCT05609396) | Dublin City University | 2022-05-03 |
| Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors (NCT07121829) | Day One Biopharmaceuticals, Inc. | 2022-05-02 |
| Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy (NCT05031975) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2022-05-02 |
| Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC (NCT06002789) | Sixth Affiliated Hospital, Sun Yat-sen University | 2022-05-01 |
| Colorectal Cancer Screening Based on Predicted Risk (NCT05357508) | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | 2022-05-01 |
| An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC) (NCT05340231) | Gang Wu | 2022-05-01 |
| Study on the Diagnostic Value of Multi-omics Combined Detection for Precancerous Lesions of CRC (NCT05530746) | Changhai Hospital | 2022-05-01 |
| Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence (NCT05587452) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-05-01 |
| Low Tie Versus High Tie of the Inferior Mesenteric Vein During Colorectal Cancer Surgery: A Randomized Clinical Trial (NCT05411783) | San Carlo di Nancy Hospital | 2022-05-01 |
| The Diverticulitis Study (NCT06023004) | University of Aarhus | 2022-05-01 |
| A Small-sample, Real-world Study of Sintilimab Plus Bevacizumab/Cetuximab Plus XELOX Regimen for Conversion Therapy in Patients With Advanced Colorectal Cancer (NCT05544812) | Xijing Hospital | 2022-05-01 |
| Informed Choice - Compass (NCT05246839) | Exact Sciences Corporation | 2022-04-28 |
| Hand-Foot Exercises for Chemotheraphy Induced Peripheral Neuropathy Pain, Falls and Quality of Life in Colorectal Cancer (NCT05873829) | Gulhane Training and Research Hospital | 2022-04-25 |
| Application of FIT-DNA Detection in Following Colorectal Cancer Resection-Implications for Surveillance (NCT05528783) | Sun Yat-sen University | 2022-04-25 |
| Michigan Genetic Hereditary Testing (MiGHT) (NCT05162846) | University of Michigan Rogel Cancer Center | 2022-04-21 |
| A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours (NCT05363605) | Fusion Pharmaceuticals Inc. | 2022-04-20 |
| Prognostic Value of Effort-independent Cardiopulmonary Exercise Test Variables for Postoperative Complications After Elective Colorectal Surgery (NCT05331196) | VieCuri Medical Centre | 2022-04-15 |
| Association Between New Effort-independent Cardiopulmonary Exercise Test Variables and Postoperative Complications After Elective Colorectal Surgery (NCT05483179) | VieCuri Medical Centre | 2022-04-15 |
| Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation (NCT05288205) | Allist Pharmaceuticals, Inc. | 2022-04-14 |
| Cardiopulmonary Exercise Test Data Averaging Methods and Preoperative Risk Assessment (NCT05353127) | VieCuri Medical Centre | 2022-04-12 |
| Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors (NCT05194735) | Alaunos Therapeutics | 2022-04-04 |
| Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis (NCT06884839) | Minia University | 2022-04-01 |
| Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer (NCT05327751) | Tanta University | 2022-04-01 |
| TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer (NCT05314101) | Fujian Cancer Hospital | 2022-04-01 |
| A Community Population Screening Cohort Study Based on Polygene Methylation Detection for Colorectal Cancer in Yangzhou (NCT05336539) | Singlera Genomics Inc. | 2022-04-01 |
| Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients (NCT07320950) | Sun Yat-sen University | 2022-04-01 |
| Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers (NCT04916236) | The Netherlands Cancer Institute | 2022-03-31 |
| Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer (NCT06428487) | Blokhin's Russian Cancer Research Center | 2022-03-31 |
| A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys (NCT04990895) | AHS Cancer Control Alberta | 2022-03-30 |
| Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP) (NCT05383976) | Abramson Cancer Center at Penn Medicine | 2022-03-29 |
| Retrospective Analysis of Colorectal Cancer Screening Results (NCT05374369) | Creative Biosciences (Guangzhou) Co., Ltd. | 2022-03-29 |
| Feasibility, Reliability, and Satisfaction of CEA Using Home Based (Automated) Capillary Blood Sampling (NCT05646030) | Erasmus Medical Center | 2022-03-25 |
| Validation of a microRNA-based Fecal (miRFec) Test for Colorectal Cancer Screening, Surveillance and Diagnosis (NCT05346757) | Fundacion Clinic per a la Recerca Biomédica | 2022-03-23 |
| Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (NCT04257526) | International Agency for Research on Cancer | 2022-03-23 |
| Connecting Audio and Radio Sensing Systems to Improve Care at Home (NCT05344950) | UNC Lineberger Comprehensive Cancer Center | 2022-03-21 |
| Clinical Application of Carbon Nanoparticles in Lymph Node Tracing and Surgery Guiding of Colorectal Cancer (NCT06783985) | Sir Run Run Shaw Hospital | 2022-03-16 |
| Lifestyle Intervention After Colonoscopy (LIFE-SCREEN Pilot) (NCT05273931) | Centre Leon Berard | 2022-03-16 |
| CITRuS Stage 1; Feasibility (NCT04697394) | Royal Surrey County Hospital NHS Foundation Trust | 2022-03-15 |
| Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer (NCT05220800) | Zealand University Hospital | 2022-03-01 |
| Comparison of Method for Skin Closure in Colorectal Cancer. (NCT06549803) | Yoon Suk Lee | 2022-03-01 |
| Effects of Preoperative Correction of Anemia With Intravenously Iron in Colorectal Cancer Patients. (NCT05221957) | Zealand University Hospital | 2022-03-01 |
| Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors (NCT05235607) | Sichuan University | 2022-03-01 |
| Single cEll pRofiling PErsistaNce To ImmuNothErapy (NCT06680739) | Vall d'Hebron Institute of Oncology | 2022-03-01 |
| Preoperative 3D Models and Shared Decision-making (NCT06625008) | Vanderbilt University Medical Center | 2022-03-01 |
| Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients (NCT04728139) | Assiut University | 2022-03-01 |
| Clinical Efficacy Evaluation of a Computer-aided Colonoscopy as Compared With the Standard Colonoscopy. (NCT05240625) | National Taiwan University Hospital | 2022-03-01 |
| Robotic Top-down Intersphincteric Resection (NCT05961969) | National Taiwan University Hospital | 2022-02-21 |
| The Impact of Choice on Colorectal Cancer Screening (NCT05275530) | University of California, Los Angeles | 2022-02-21 |
| Exercise Intervention to Improve Quality of Life in Patients With Colorectal Cancer (NCT05224518) | National Taiwan University Hospital Hsin-Chu Branch | 2022-02-21 |
| Increasing Engagement With Messages Regarding CRC Screening Among Adults Aged 45-49 (NCT05281159) | University of California, Los Angeles | 2022-02-21 |
| Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test (NCT05232721) | Shandong University | 2022-02-20 |
| GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results (NCT05183243) | Suzhou Genhouse Bio Co., Ltd. | 2022-02-20 |
| P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors (NCT05239143) | Poseida Therapeutics, Inc. | 2022-02-15 |
| ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study (NCT05084833) | Ann & Robert H Lurie Children's Hospital of Chicago | 2022-02-14 |
| Vitamin D Intervention and Associated Changes in the Gut Microbiome and Vitamin D Levels in Healthy Adults (NCT05387876) | Baylor University | 2022-02-14 |
| Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) (NCT05259696) | Palleon Pharmaceuticals, Inc. | 2022-02-11 |
| A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer (NCT05255588) | Genomictree, Inc. | 2022-02-10 |
| Adenoma Detection Rate of 3D Colonoscopy (NCT05153746) | National Taiwan University Hospital | 2022-02-10 |
| Comparing Detection of Standard Colonoscopy, CAD-EYE and Combined CAD-EYE and G-EYE® Aided Colonoscopy (NCT05237310) | Smart Medical Systems Ltd. | 2022-02-02 |
| Hybrid-sensor Breath Analysis for Colorectal Cancer Screening (NCT05173077) | University of Latvia | 2022-02-01 |
| mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer (NCT05200299) | First Affiliated Hospital of Wenzhou Medical University | 2022-02-01 |
| Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer (NCT04753359) | University of Illinois at Chicago | 2022-02-01 |
| A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy (NCT05511051) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-02-01 |
| Safety and Immune Response to FMPV-1 (NCT05238558) | Hubro Therapeutics AS | 2022-01-31 |
| Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal Cancer (NCT05116085) | BeiGene | 2022-01-26 |
| Walnuts and Colon Health (NCT05195970) | UConn Health | 2022-01-24 |
| Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients (NCT06780423) | Hasselt University | 2022-01-23 |
| Implication of Genetic Variations in Long Intergenic Non-coding RNA 00511 (LINC00511) in Colorectal Cancer (NCT06534242) | Ain Shams University | 2022-01-20 |
| Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention (NCT05390398) | Wageningen University | 2022-01-18 |
| SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study (NCT05010850) | SafeHeal Inc | 2022-01-17 |
| Perioperative Testosterone Replacement Therapy in Sarcopenic Male Colorectal Cancer Patients (NCT05367284) | London North West Healthcare NHS Trust | 2022-01-15 |
| Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer Recurrence (NCT06143644) | Sun Yat-sen University | 2022-01-15 |
| WT1 in Colorectal Adenocarcinoma (NCT07778628) | Sohag University | 2022-01-15 |
| Exercise as Medicine for People With Cancer Sweden (NCT05064670) | Karolinska Institutet | 2022-01-11 |
| Fecal Immunochemical Test for Advanced Adenoma Detection in Colorectal Cancer Screening (NCT05200611) | Shandong University | 2022-01-04 |
| Technology-Based Cancer Screening Intervention (NCT04535492) | Medical University of South Carolina | 2022-01-04 |
| Text-based Colorectal Cancer Prevention Pilot (NCT05004376) | University of Rochester | 2022-01-03 |
| Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research (NCT05398380) | Hospital Vall d'Hebron | 2022-01-01 |
| Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators (NCT04722341) | Cedars-Sinai Medical Center | 2022-01-01 |
| Immune Checkpoints in Intraabdominal Ascites Fluid (NCT04540159) | Istanbul Training and Research Hospital | 2022-01-01 |
| Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer (NCT04842006) | Helsinki University Central Hospital | 2021-12-20 |
| Neutrophil-to-Lymphocite Ratio (NLR) and C-reactive Protein (CRP) as New Markers in Diagnosis and Prediction of Colorectal Cancer (NCT05129046) | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | 2021-12-15 |
| CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer (NCT05210283) | Exact Sciences Corporation | 2021-12-15 |
| RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer (NCT05862051) | Australasian Gastro-Intestinal Trials Group | 2021-12-14 |
| A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations (NCT05163028) | HUYABIO International, LLC. | 2021-12-13 |
| Real-Time Feedback (RTFB) to Improve Colonoscopy (NCT05241210) | University of Minnesota | 2021-12-13 |
| Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer (NCT05202314) | Beijing Chao Yang Hospital | 2021-12-12 |
| Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin (NCT05118724) | AIO-Studien-gGmbH | 2021-12-10 |
| A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) (NCT05104567) | Sanofi | 2021-12-09 |